New Hepatitis-C drugs 99% cheaper in India

According to the World Health Organization (WHO), about 130-170 million people worldwide are chronically infected with HCV, and more than 350,000 people die due to the HCV-related liver diseases. For those already infected, effective treatment strategies exist for Hepatitis C and the arrival of newer short duration oral anti-viral drugs have radically changed the way Hepatitis C is treated.

Sofosbuvir has eliminated the Hepatitis C virus in 90 percent of cases within 24 weeks. Sofosbuvir was discovered in the US and introduced by Gilead Sciences in 2013. “It was initially priced at $84,000 for the full course of treatment, $84,000 list price for Sovaldi and $94,500 for Harvoni. Gilead’s Harvoni and Sovaldi are available in India at lower prices–as low as 1% of the U.S. sticker price.

How Med Access can help you with easy and fast access to Hepatitis C treatment in India?

1. We will help you in selecting the best doctors and right hospitals.

2. We will seek multiple opinions to arrive at the right, reliable and accurate diagnosis.

3. We will assist you in getting the investigations from the right diagnostic centers.

4. We will help you in procuring the medicines from the reliable sources.

5. We can assist you with the logistics aspect of your travel, facilitation in visa process, accommodation and food

6. We will professionally manage your entire treatment and trip to India.

You may be living in any part of the world, find easy and fast access to Hepatitis C Treatment in India through Med Access India